To our knowledge, the first catalogue of lncRNA potentially involved in lipid metabolism was proposed by Chen in 2016 [31] and included the 5 lncRNA, called lncLSTR, HULC, APOA1-AS, lincRNA-DYNLRB2–2 and SRA. The same year, Zhou et al. [33] published a broader review of lncRNA genes potentially involved in lipid and glucose metabolisms and related diseases (atherosclerosis, type 2 diabetes, insulin resistance) in which TRIBAL, ANRIL, lncLSTR, AT102202, APOA1-AS, lincRNA-DYNLRB2–2, RP5-833A20.1 and CRNDE were described as involved in lipid metabolism. Here, SREBF2-AS1 is linked to atherosclerosis.